Is Perrigo Company PLC (PRGO) overvalued? · rev $4.37B
Perrigo Company PLC (PRGO) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Perrigo Company PLC (PRGO) looks expensive on cached numbers — not a short thesis.
Latest reported PRGO revenue for 2024-12-31 was $4.37B. Net income was -$171.8M. Revenue was down 6.1% from 2023-12-31 to 2024-12-31. PRGO currently screens at market cap $1.48B.
PRGO currently screens at market cap $1.48B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PRGO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PRGO stock page for the full model, not this heading.
Not investment advice.